Target intelligence / Profile preview

Calmin pseudogene

Molecular classification: Pseudogene

Overview

Calmin pseudogene (Ensembl: ENSG00000287111) is a genomic DNA segment homologous to the calmin (CLMN) gene, but with mutations disrupting its ability to encode a protein. Pseudogenes like this are formed by gene duplication or retrotransposition and accumulate disabling mutations, rendering them nonfunctional. They do not contribute direct protein or receptor activity and are not considered therapeutic drug targets. In some contexts, pseudogenes may give rise to non-coding RNAs with regulatory effects, but there is no evidence for such function in calmin pseudogene. In summary, ENSG00000287111 refers to a nonfunctional calmin-related DNA sequence, not a receptor, enzyme, or other therapeutic target. All major structured entries should be null except for identification as a pseudogene.

Other names: Calponin-like, transmembraneCLMN pseudogene

Beyond the preview

Go deeper on Calmin pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calmin pseudogene.

Explore the full profile